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Objective
To investigate HIV-related immunodeficiency as a risk fac-
tor for hepatocellular carcinoma (HCC) among persons
infected with HIV, whilst controlling for the effect of fre-
quent co-infection with hepatitis C and hepatitis B
viruses.
Design
A case-control study nested in the Swiss HIV Cohort Study
(SHCS).
Methods
Twenty-six HCC cases were identified in the SHCS or
through linkage with Swiss Cancer Registries, and were
individually matched to 251 controls by SHCS centre,
gender, HIV-transmission category, age and year at enrol-
ment. Odds ratios (OR) and corresponding confidence
intervals (CI) were estimated by conditional logistic
regression.
Results
All cases and 53 percent of controls (92% of controls
among intravenous drug users [IDU]) were positive for
hepatitis B superficial antigen (HBsAg) or antibodies
against HCV (anti-HCV). HCC cases included 14 IDU
(three positive for HBsAg, 13 for anti-HCV), and 12 men
having sex with men (MSM)/heterosexual/others (11 pos-
itive for HBsAg, three for anti-HCV), revealing a strong
relationship between HIV transmission route and hepati-
tis viral type. Latest CD4+ cell count was significantly
associated with HCC (OR for lowest versus highest tertile
= 4.26, 95% CI: 1.18–15.5). This effect was concentrated
among MSM/heterosexual/others (OR = 18.2, 95% CI:
1.61–207) rather than IDU (OR = 1.79, 95% CI: 0.39–
8.23). HAART use was not significantly associated with
HCC risk (OR for ever versus never = 0.59, 95% CI: 0.18–
1.91).
Conclusion
More than CD4+ cell counts increased the risk for HCC
among persons infected with HIV, an effect that was par-
ticularly evident for HBV-related HCC arising in non-
IDUs.
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